13F HOLDINGS REPORT
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Quarter ended Q3 2025 · Filed November 6, 2025 · Accession 0001553936-25-000013
Total Value
$30.9M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TAYSHA GENE THERAPIES INC (TSHA US) | TSHA | 3,700,000 | $12.1M | 39.11% |
| 2 | FORTE BIOSCIENCES INC (FBRX US) | FBRX | 786,647 | $11.8M | 38.15% |
| 3 | ALUMIS INC (ALMS US) | ALMS | 1,399,250 | $5.6M | 18.05% |
| 4 | ZENTALIS PHARMACEUTICALS INC (ZNTL US) | ZNTL | 961,486 | $1.5M | 4.69% |